Humana (HUM) stock
Last close $380.00 on 2026-11-19 (-1.50%) · Sector: Healthcare
Humana is a large U.S. health insurance company that sells health plans, including Medicare Advantage plans for older adults, and it also runs care services through its CenterWell unit. It makes most of its money from the premiums members pay for coverage and from fees for healthcare services.
Humana's revenue has been growing, up 22.0% over the past year, but its profit has bounced between small gains and losses from quarter to quarter. Over the past year the stock returned 70.2%, well ahead of the S&P 500's 9.7%, though it is still 17.9% below its 52-week high. Two insiders sold $2.6 million of stock in the last 90 days and no insiders bought, and the stock has risen after about half of its recent earnings reports and fallen after the others.
Key numbers
- Market cap: $46.3B
- Revenue (last 12 months): $154.20B
- Revenue growth: +22.0%
- Operating margin: 1.5%
- P/E: 36.9
- P/S: 0.3
- Debt to equity: 0.61
- Current ratio: 1.65
Quality score
Overall 39/100 · growth 48 · profitability 22 · financial health 49 · value 36
Performance and risk
1-year return +70.2% vs S&P 500 +9.7% · volatility 48.1% (S&P 500 13.8%) · largest drop -42.4% · beta 0.54
Stock move the day after earnings
- 2026-02-11: -3.3%
- 2026-04-29: +5.8%
- 2026-07-29: -6.0%
- 2026-11-06: +5.3%
Congress trades (90 days)
1 buys, 0 sells
Insider trades (12 months)
Bought $0.2M · sold $2.6M
HUM stock research · HUM options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.